Search
Por primera vez, un fármaco dirigido está mostrando resultados prometedores en el tratamiento del cáncer pulmonar de células no pequeñas causado por una mutación llamada KRAS-G12D.
The collective efforts of the “TeamLabs” will accelerate discoveries in glioblastoma, ovarian, and pancreatic cancers
Two important clinical trials to increase treatment options for mantle cell lymphoma patients are currently recruiting patients.
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments.
Memorial Sloan Kettering Cancer Center is proud and honored to announce it has been named the number one hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals.
The atomic structure of an elusive type of membrane protein has finally been solved by scientists at the Sloan Kettering Institute.
MSK researchers are rethinking the relationship between metabolism and cancer, and finding insights in some unexpected places. Your beer glass, for example.
Memorial Sloan Kettering Cancer Center (MSK) researchers presented results of their latest research at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition held in San Diego from December 7 to 10, 2024.
MSK’s new Robert and Kate Niehaus Center for Inherited Cancer Genomics is using the latest in gene sequencing technologies to discover the inherited causes of cancer.